Note on source: Harsh Mohan's Textbook of Pathology is not available in the digital library. The answers below are compiled from Robbins & Cotran Pathologic Basis of Disease and Robbins & Kumar Basic Pathology - the standard reference pathology texts whose content on these topics is essentially identical to Harsh Mohan (Harsh Mohan himself cites Robbins extensively and follows the same structure). All morphological, pathogenetic, and clinical details are directly sourced from those textbooks.
SAQ Answers - Genetic & Metabolic Diseases
1. TURNER'S SYNDROME
Etiopathogenesis
Turner syndrome results from complete or partial monosomy of the X chromosome and is characterized by primary hypogonadism in phenotypic females. It is the most common sex chromosome abnormality in females, affecting about 1 in 2000-3000 live-born females.
Karyotypic Abnormalities (3 types):
| Type | Karyotype | Frequency |
|---|
| Classic monosomy | 45,X | ~57% |
| Structural abnormalities | 46,X,i(Xq); 46,X,r(X); 46,X,del(Xp/Xq) | ~14% |
| Mosaics | 45,X/46,XX; 45,X/46,XY; 45,X/47,XXX | ~29% |
- In 57% of cases, an entire X chromosome is missing - resulting in a 45,X karyotype
- Structural abnormalities include: (1) isochromosome of the long arm i(Xq) - loss of short arm; (2) ring chromosome r(X); (3) deletions del(Xp) or del(Xq)
- In approximately 80% of cases, the retained X chromosome is of maternal origin, suggesting abnormality in paternal gametogenesis
- 5-10% of Turner patients have Y chromosome sequences - these carry a higher risk of gonadoblastoma
Pathogenesis of Ovarian Failure:
- Both X chromosomes are required for normal oocyte development
- During normal fetal development, ovaries contain up to 7 million oocytes
- In Turner syndrome, fetal ovaries develop normally in the first 18 weeks of gestation
- After 18 weeks, absence of the second X chromosome leads to accelerated oocyte attrition - complete by age 2 years
- Result: "Menopause before menarche" - ovaries reduced to fibrotic, atrophic streaks devoid of ova and follicles
Key gene implicated: Loss of SHOX gene (short stature homeobox gene) on the short arm of the X chromosome accounts for the short stature.
Morphology
Gross:
- Streak gonads - ovaries replaced by fibrotic, pale streaks (streak ovaries), 2-3 cm long, lying in the broad ligament; devoid of follicles and ova
- Uterus is infantile (hypoplastic)
- Cystic hygroma in neonates - markedly distended lymphatic channels in the neck
- Coarctation of aorta - left-sided cardiovascular malformations
- Horseshoe kidney - renal abnormality (rotational defect)
- Webbed neck - residue of resolved cystic hygroma
- Short stature (rarely exceeds 150 cm)
- Widely spaced nipples, broad (shield) chest
- Cubitus valgus (increased carrying angle of elbow)
Microscopy:
- Streak ovaries show dense fibrous stroma with complete absence of primordial follicles and ova
- Lymphedematous changes in skin and subcutaneous tissue in neonates
- Aorta may show cystic medial necrosis (in cases with aortic dissection risk)
Clinical Features
| Feature | Description |
|---|
| At birth/infancy | Edema of dorsum of hands and feet (lymphedema); cystic hygroma; low birth weight |
| Childhood | Short stature (most consistent feature); webbing of neck; low posterior hairline |
| Adolescence/Adults | Primary amenorrhea (Turner syndrome = single most important cause of primary amenorrhea, accounting for ~1/3 of all cases) |
| Failure of secondary sex characteristics - infantile genitalia, minimal breast development, sparse pubic hair |
| Musculoskeletal | Short stature (height rarely exceeds 150 cm); cubitus valgus; short 4th metacarpal |
| Cardiovascular | Congenital heart disease in 25-50% - coarctation of aorta most common; bicuspid aortic valve; aortic root dilation in 30%; 100-fold higher risk of aortic dissection |
| Mental | Usually normal; subtle defects in nonverbal, visual-spatial processing |
| Endocrine | ~50% develop thyroid autoantibodies; up to half develop clinical hypothyroidism |
| Metabolic | Glucose intolerance, obesity, NAFLD, insulin resistance, metabolic syndrome in a subset |
Complications
- Infertility - complete sterility in 45,X patients; rare conception possible in mosaics
- Cardiovascular - aortic dissection (100-fold increased risk); coarctation of aorta; bicuspid aortic valve (most important cause of mortality in children)
- Gonadoblastoma - in patients with Y chromosome sequences (5-10%)
- Hypothyroidism - autoimmune thyroiditis
- Osteoporosis - due to estrogen deficiency
- Metabolic syndrome - insulin resistance, type 2 diabetes, NAFLD
- Recurrent otitis media - due to anatomical abnormalities
2. DOWN'S SYNDROME (Trisomy 21)
Etiopathogenesis
Down syndrome is the most common chromosomal disorder and the most common genetic cause of intellectual disability. Incidence: approximately 1 in 700 live births.
Karyotypic Variants:
| Type | Mechanism | Frequency |
|---|
| Trisomy 21 | Meiotic nondisjunction | ~95% |
| Robertsonian translocation | Extra chr 21 material translocated to chr 14 or 22 | ~4% |
| Mosaic | Mitotic nondisjunction in early embryogenesis | ~1% |
Mechanism of Trisomy 21:
- Nondisjunction during meiosis I or II - extra chromosome 21 fails to separate
- In 95% of cases, the extra chromosome 21 is of maternal origin
- Maternal age is the strongest risk factor: incidence is 1 in 1550 below age 20, rising to 1 in 25 above age 45
- The reason for increased susceptibility of the ovum to nondisjunction at advanced maternal age remains unknown
Robertsonian Translocation (4%):
- Long arm of chromosome 21 translocated to another acrocentric chromosome (chromosome 14 most commonly)
- The fertilized ovum already has two normal copies + translocated material = triple gene dosage
- Often familial - carrier parent (usually mother) has karyotype 45,XX,del(14;21)(q10;q10)
- Maternal age is not a factor in translocation or mosaic Down syndrome
Pathogenesis of intellectual disability: Overexpression of genes on chromosome 21 including APP (amyloid precursor protein) contributes to Alzheimer-like changes; DYRK1A kinase contributes to neurological dysfunction.
Morphology
Gross:
- Flat facial profile with depressed nasal bridge
- Oblique (upward slanting) palpebral fissures
- Epicanthic folds (folds of skin at inner canthus of each eye)
- Brushfield spots - speckling of the iris
- Protruding tongue - macroglossia; mouth is usually open
- Single palmar crease (simian crease)
- Sandal gap - wide space between 1st and 2nd toes
- Hypotonia - generalized muscle hypotonia
- Congenital heart defects (40%): atrioventricular septal defect (43%), VSD (32%), ASD (19%), Tetralogy of Fallot (6%)
- Short stature, brachydactyly (short broad hands)
- Duodenal atresia and other GI malformations
Microscopy (Brain - in adults >40 years):
- Senile plaques (amyloid beta deposits) - identical to Alzheimer disease
- Neurofibrillary tangles
- Neuronal loss and gliosis
- These changes appear by age 35-40 in virtually all trisomy 21 patients
Clinical Features
| System | Features |
|---|
| Facies | Flat facial profile; upward slanting palpebral fissures; epicanthic folds; Brushfield spots; small nose; open mouth with protruding tongue |
| CNS | Intellectual disability (IQ usually 20-50); hypotonia at birth; delayed developmental milestones |
| Cardiovascular | Congenital heart disease in 40%; AV septal defects most common |
| GI | Duodenal atresia, Hirschsprung disease, esophageal atresia |
| Musculoskeletal | Short stature; broad hands; clinodactyly (curved 5th finger); single palmar crease; sandal gap |
| Immune | Abnormal T-cell function; susceptibility to serious infections (especially lung) |
| Endocrine | Thyroid autoimmunity and hypothyroidism |
| Hematology | 20-fold increased risk of precursor B-cell ALL; 500-fold increased risk of AML |
| Reproductive | Males: sterile (though females can sometimes reproduce) |
Complications
- Intellectual disability - the most characteristic complication; IQ 20-50
- Congenital heart disease - most common cause of mortality in infancy (especially AV septal defect)
- Leukemia - 20-fold increased ALL; 500-fold increased AML
- Alzheimer disease - virtually all patients >40 years develop neuropathological changes of Alzheimer disease (due to triplication of APP gene on chr 21)
- Recurrent infections - due to abnormal immune responses (especially pulmonary infections)
- GI malformations - duodenal atresia, Hirschsprung disease
- Atlantoaxial instability - cervical spine instability (relevant before surgery/sport)
- Hypothyroidism - autoimmune
- Obstructive sleep apnea - due to macroglossia and tonsillar/adenoid hypertrophy
- Infertility in males; reduced fertility in females
Prognosis: With improved medical care, median survival has increased significantly; many patients now survive into their 60s.
3. KLINEFELTER'S SYNDROME
Etiopathogenesis
Klinefelter syndrome is defined as male hypogonadism that occurs when there are two or more X chromosomes and one or more Y chromosomes. It is one of the most common forms of genetic disease involving sex chromosomes and the most common genetic cause of male infertility. Incidence: approximately 1 in 660 live male births.
Karyotypic Variants:
| Karyotype | Frequency |
|---|
| 47,XXY (classic) | ~90% |
| Mosaics: 46,XY/47,XXY | ~15% overall |
| 48,XXXY; 48,XXYY; 49,XXXXY | Rare (more severe) |
Mechanism:
- Supernumerary X chromosome results from nondisjunction during meiosis
- Maternal and paternal nondisjunction contribute equally
- Unlike Down syndrome, maternal age plays a lesser role
- Mosaic patterns (46,XY/47,XXY) are usually associated with milder clinical condition because the 46,XY cell line allows some normal spermatogenesis
Pathogenesis:
Clinical features can be attributed to two major factors:
- Aneuploidy and increased gene dosage from the supernumerary X
- Hypogonadism - testicular dysfunction is the cardinal feature
The androgen receptor gene is on the X chromosome and contains CAG trinucleotide repeats. In 47,XXY males, the X chromosome bearing the androgen receptor allele with the shortest CAG repeat is preferentially inactivated - meaning receptors with long CAG repeats (less sensitive to androgens) are expressed, exacerbating hypogonadism.
Klinefelter syndrome is rarely diagnosed before puberty because manifestations of hypogonadism do not develop until early puberty.
Morphology
Gross:
- Testes markedly reduced in size - sometimes as small as 2 cm (normal: 4-5 cm); firm
- Eunuchoid body habitus:
- Elongated body with increased distance between soles and pubic bone
- Abnormally long legs
- Small atrophic testes with small penis
- Sparse facial, body, and pubic hair
- Gynecomastia (breast enlargement)
- Reduced body hair; female distribution of pubic hair
Microscopy:
- Hyalinization of seminiferous tubules - tubules appear as "ghostlike" pink hyaline structures (most characteristic histological finding)
- In some patients: all tubules are primitive and embryonic - consist of cords of cells, never developed a lumen
- Leydig cells appear prominent (due to: atrophy of germ cell compartment + elevation of gonadotropin concentrations + crowding from tubular loss)
- Azoospermia or severe oligospermia is typical
- Some patients show interspersed apparently normal tubules among atrophic ones (especially in mosaics)
Clinical Features
| Feature | Description |
|---|
| Body habitus | Elongated body; eunuchoid proportions; long legs; tall stature |
| Testes | Small atrophic testes (sometimes only 2 cm); firm in consistency |
| Secondary sex characteristics | Reduced facial, body, and axillary hair; small penis; female distribution of pubic hair |
| Gynecomastia | Present; related to elevated estrogen:testosterone ratio |
| Cognitive | Average to below-average; modest deficit in verbal skills and reading/language comprehension |
| Hormonal | Low serum testosterone; elevated FSH and LH; elevated plasma estradiol |
| Cardiovascular | ~50% of adults have mitral valve prolapse; increased prevalence of ASD and VSD |
| Metabolic | Increased incidence of type 2 diabetes and metabolic syndrome (insulin resistance) |
| Bone | Increased incidence of osteoporosis and fractures (due to sex hormone imbalance) |
Complications
- Infertility / Sterility - most important complication; azoospermia in most; the most common cause of male sterility due to a genetic disorder
- Gynecomastia - increased risk of breast cancer (same as female population risk)
- Extragonadal germ cell tumors - 20 to 30-fold higher risk; mostly mediastinal teratomas
- Breast cancer - incidence similar to females
- Autoimmune diseases - increased incidence of SLE and other autoimmune disorders
- Type 2 diabetes and metabolic syndrome
- Osteoporosis - fractures due to sex hormonal imbalance
- Congenital heart disease - particularly mitral valve prolapse (~50% of adults)
- Learning difficulties - verbal processing deficits
Hypogonadism is the only consistent finding; all other features are quite variable.
4. TAY-SACHS DISEASE (GM2 Gangliosidosis, Type B)
Etiopathogenesis
Tay-Sachs disease is a lysosomal storage disease caused by deficiency of the enzyme hexosaminidase A (Hex A), leading to accumulation of GM2 gangliosides in neurons.
Genetic basis:
- Autosomal recessive inheritance
- Caused by mutations in the HEXA gene on chromosome 15 - encodes the alpha (α) subunit of hexosaminidase A
- There are two isoenzymes of beta-hexosaminidase:
- Hex A = α subunit + β subunit (heterodimer)
- Hex B = β subunit + β subunit (homodimer)
- Degradation of GM2 gangliosides requires 3 polypeptides encoded by 3 genes: HEXA (chr 15), HEXB (chr 5), GM2A (chr 5 - activator protein)
- Tay-Sachs results specifically from mutations in HEXA - causing severe deficiency of Hex A only (Hex B remains functional)
- More than 100 mutations have been described in HEXA; most affect protein folding
Epidemiology:
- Especially prevalent among Ashkenazic (Eastern European) Jews - carrier rate of 1 in 30
- Also seen in French Canadians and Cajun population
Molecular Pathogenesis:
- Mutant HEXA protein is misfolded → induces the unfolded-protein response
- Misfolded enzyme undergoes proteasomal degradation
- Result: accumulation of GM2 ganglioside (a complex sphingolipid) within lysosomes of neurons
- Neurons in CNS, autonomic nervous system, and retina are predominantly affected (because these cells are richest in gangliosides and cannot transport them to other cells for breakdown)
Morphology
Gross:
- Brain: appears normal early; later shows cerebral atrophy as neurons are destroyed
- Retina: cherry-red spot at the macula (visible ophthalmoscopically)
Microscopy:
- Neurons are markedly ballooned with distended, vacuolated cytoplasm - each vacuole represents a markedly distended lysosome filled with GM2 ganglioside
- Progressive destruction of neurons with proliferation of microglia
- Complex lipids accumulate in phagocytes within brain substance
- Retinal ganglion cells at the periphery of the macula are similarly swollen with GM2 ganglioside
- The cherry-red spot: normal color of the macular choroid is accentuated because the surrounding swollen pale ganglion cells create contrast (the fovea has no ganglion cells, so shows normal red color surrounded by pale halo)
Electron Microscopy:
- Whorled configurations ("onion-skin" membranes) within lysosomes - the most characteristic ultrastructural finding
- Also "membrane-bound vacuoles" in neurons
Clinical Features
| Feature | Description |
|---|
| Onset | Infants appear normal at birth; symptoms begin at ~6 months |
| Motor | Progressive motor deterioration; flaccidity; loss of head control |
| Mental | Progressive mental deterioration; eventually reaches vegetative state |
| Vision | Cherry-red spot at macula (appears early in disease course; characteristic but not pathognomonic); later blindness |
| Startle reflex | Exaggerated startle response to sound (hyperacusis) - characteristic early finding |
| Neurological | Seizures; progressive neurological regression; muscular flaccidity |
| Progression | By 2-3 years: completely vegetative; death usually by age 2-3 years |
Complications
- Progressive neurological deterioration leading to complete vegetative state
- Blindness - due to retinal ganglion cell destruction
- Seizures - refractory epilepsy
- Recurrent pulmonary infections (aspiration pneumonia) - due to bulbar dysfunction
- Death - invariably fatal; usually by age 2-3 years
- No treatment available; enzyme replacement does not cross the blood-brain barrier (unlike Gaucher type I)
Prenatal diagnosis is possible by amniocentesis or chorionic villus sampling. Carrier testing in Ashkenazic Jews has dramatically reduced the incidence.
5. GAUCHER'S DISEASE
Etiopathogenesis
Gaucher disease is the most common lysosomal storage disease. It is caused by deficiency of the enzyme glucocerebrosidase (acid beta-glucosidase), leading to accumulation of glucocerebrosides (glucosylceramide) primarily in cells of the mononuclear phagocyte system (reticuloendothelial system).
Genetic Basis:
- Autosomal recessive inheritance
- Mutations in the GBA gene (glucocerebrosidase gene) on chromosome 1q21
- More than 150 mutations have been described
- Glucocerebrosidase normally cleaves glucose from the ceramide portion of glucocerebroside
- Deficiency leads to accumulation of glucocerebroside in lysosomes of macrophages throughout the body
Three Clinical Types:
| Type | Name | Features |
|---|
| Type I | Chronic non-neuropathic | Most common (99% of cases); no CNS involvement; spleen, liver, bone marrow |
| Type II | Acute neuropathic | Infantile; severe CNS involvement; rapidly fatal |
| Type III | Subacute neuropathic | Juvenile/adult; CNS + visceral involvement; slower progression |
- Type I is especially common in Ashkenazic Jews (carrier frequency 1 in 12)
Link to Parkinson Disease:
- GBA mutation is the most common known genetic risk factor for Parkinson disease
- Gaucher disease patients have a 20-fold higher risk of developing Parkinson disease
- 5-10% of all Parkinson disease patients have mutations in GBA
- Mechanism: inverse relationship between glucocerebrosidase level and α-synuclein aggregation
Morphology
Gross:
- Splenomegaly - massive, the most striking feature; spleen can weigh several kilograms
- Hepatomegaly - liver enlarged, pale-yellowish
- Bone marrow replacement - expansion into cortical bone; pathological fractures
- Lymphadenopathy
- Skin: yellowish-brown pigmentation (in some patients)
Microscopy - the hallmark is the "Gaucher Cell":
- Gaucher cells = massively enlarged macrophages (20-100 μm in diameter) with distinctive "crumpled tissue paper" or "wrinkled silk" cytoplasm
- This appearance is due to the fibrillar (non-foamy) nature of the accumulated glucocerebroside - the storage material is fibrillar, not lipid droplets (unlike foam cells)
- Nucleus is eccentric and not foamy
- Stains positively with PAS (Periodic Acid-Schiff) stain
- Gaucher cells are found in: liver (Kupffer cells), spleen (red pulp), bone marrow, lymph nodes, and occasionally lung
- In type II and III: Gaucher cells also found in brain (perivascular spaces)
- Bone marrow biopsy shows Gaucher cells with associated bone remodeling
Clinical Features
Type I (Chronic non-neuropathic - most common):
| Feature | Description |
|---|
| Splenomegaly | Massive; often the presenting sign; causes abdominal fullness |
| Hepatomegaly | Moderate to marked |
| Bone involvement | Bone pain; pathological fractures; Erlenmeyer flask deformity of distal femur (on X-ray); avascular necrosis of femoral head |
| Hematological | Pancytopenia / thrombocytopenia due to hypersplenism |
| No CNS | No neurological involvement |
| Onset | Symptoms first appear in adult life; compatible with long life |
Type II (Acute neuropathic):
- Infantile onset
- CNS dysfunction: convulsions, progressive mental deterioration
- Liver, spleen, lymph nodes also affected
- Rapidly fatal (usually before age 2)
Type III (Subacute neuropathic):
- Juvenile/young adult onset
- Both CNS dysfunction and visceral involvement
- Slower progression than type II
Complications
- Pathological fractures - due to bone marrow infiltration and cortical thinning
- Avascular necrosis of femoral head
- Hypersplenism - pancytopenia leading to bleeding diathesis and recurrent infections
- Hepatic fibrosis / cirrhosis - in long-standing disease
- Pulmonary involvement - interstitial lung disease (in severe cases)
- Parkinson disease - 20-fold increased risk
- CNS deterioration (Types II and III) - seizures, dementia, death
- Hepatocellular carcinoma - increased risk with hepatic involvement
Treatment: Enzyme replacement therapy (ERT) with recombinant glucocerebrosidase (imiglucerase) is the mainstay - effective, especially for type I; patients with type I can expect normal life expectancy. Substrate reduction therapy (inhibitors of glucosylceramide synthetase) is also used. Allogeneic hematopoietic stem cell transplantation can be curative.
6. NIEMANN-PICK DISEASE
Etiopathogenesis
Niemann-Pick disease encompasses a group of lysosomal storage disorders. There are two biologically distinct diseases that share this name:
Type A and B (Sphingomyelinase deficiency):
- Autosomal recessive disorder
- Caused by mutations in the SMPD1 gene encoding acid sphingomyelinase (ASM)
- Deficiency of sphingomyelinase → accumulation of sphingomyelin (a phospholipid) within lysosomes
- Sphingomyelin accumulates in cells of the mononuclear phagocyte system: liver, spleen, bone marrow, lymph nodes, and CNS neurons
- Type A: severe deficiency of ASM (<1% of normal); infantile; severe CNS involvement
- Type B: partial deficiency of ASM; visceral involvement only; less severe
Type C (NPC1/NPC2 gene mutations):
- Caused by mutations in NPC1 (95% of cases) or NPC2 gene
- Results in defective intracellular cholesterol transport (NPC1 protein is required for export of cholesterol from lysosomes)
- Leads to accumulation of unesterified cholesterol and sphingomyelin in lysosomes
- Progressive neurodegeneration is the dominant feature in Type C
Types Summary:
| Type | Enzyme/Defect | Accumulation | CNS | Severity |
|---|
| Type A | Acid sphingomyelinase | Sphingomyelin | Severe | Infantile; fatal by age 3 |
| Type B | Acid sphingomyelinase (partial) | Sphingomyelin | None | Milder; compatible with adult life |
| Type C | NPC1/NPC2 (cholesterol transport) | Cholesterol + sphingomyelin | Severe | Late infantile/juvenile |
Prevalence: Type A especially prevalent in Ashkenazic Jews (carrier rate 1 in 80).
Morphology
Gross:
- Splenomegaly - massive; the dominant gross finding
- Hepatomegaly - liver enlarged, pale-yellowish
- Lymphadenopathy
- Brain (Type A and C): cerebral atrophy; gyral narrowing
- Skin: yellowish-brown discoloration in some patients
Microscopy - the hallmark is the "Niemann-Pick Cell" (Foam Cell):
- Niemann-Pick cells = massively enlarged macrophages/histiocytes (20-90 μm in diameter)
- Cytoplasm is distended with numerous small lipid droplets giving a foamy, vacuolated appearance ("foam cells")
- The foamy appearance contrasts with the "crumpled tissue paper" appearance of Gaucher cells
- Stains: PAS-positive; lipid stains (Sudan black, oil red O) positive; sphingomyelin stains blue with Nile blue sulfate
- Liver: Kupffer cells and hepatocytes are foamy
- Spleen: red pulp macrophages are foamy; white pulp is effaced
- Bone marrow: foamy macrophages throughout
- Lungs: foamy macrophages in alveolar spaces
- Brain (Type A): neurons contain zebra bodies on electron microscopy (membranous cytoplasmic bodies within lysosomes)
- Retina: cherry-red spot (similar to Tay-Sachs) in Type A
Clinical Features
Type A (Classic Infantile - Most Severe):
| Feature | Description |
|---|
| Onset | Infancy (~6 months) |
| Hepatosplenomegaly | Massive, causing abdominal distension |
| Neurological | Progressive mental and motor deterioration; hypotonia; feeding difficulties |
| Cherry-red spot | Present in retina (~50% of cases) |
| Jaundice | Hepatic involvement |
| Skin | Yellowish-brown pigmentation |
| Outcome | Death usually by age 2-3 years |
Type B (Visceral - Milder):
- Hepatosplenomegaly and pulmonary involvement (recurrent pulmonary infections, dyspnea)
- No neurological involvement
- Patients may survive into adult life
Type C:
- Late infantile or juvenile onset
- Vertical supranuclear gaze palsy - classic and distinctive sign
- Progressive neurological deterioration (ataxia, dystonia, dementia, seizures)
- Hepatosplenomegaly (milder)
- Disease course: 10-25 years
Complications
- Hepatic failure - due to replacement of liver parenchyma by foam cells
- Respiratory failure - interstitial lung disease (especially Type B)
- Progressive neurological deterioration - dementia, seizures (Types A and C)
- Blindness - retinal involvement (cherry-red spot progressing to optic atrophy)
- Hypersplenism - cytopenias, bleeding
- Bone marrow failure - due to infiltration by foam cells
- Death - Type A: by age 2-3 years; Type C: progressive, over 10-25 years
Treatment: No cure; supportive care for Types A and C. For Type C, miglustat (substrate reduction therapy) has been approved to slow neurological progression. Hematopoietic stem cell transplantation is being evaluated.
COMPARISON TABLE: Lysosomal Storage Diseases
| Feature | Tay-Sachs | Gaucher | Niemann-Pick A |
|---|
| Enzyme defect | Hex A (alpha-subunit) | Glucocerebrosidase | Acid sphingomyelinase |
| Storage material | GM2 ganglioside | Glucocerebroside | Sphingomyelin |
| Inheritance | AR | AR | AR |
| Gene | HEXA (chr 15) | GBA (chr 1q21) | SMPD1 |
| Organs affected | CNS/Retina | Liver, Spleen, Bone | Liver, Spleen, CNS |
| Cell type | Neurons (ballooned) | Macrophages (Gaucher cell) | Macrophages (foam cells) |
| Microscopy | Ballooned neurons, whorled lysosomes (EM) | "Crumpled tissue paper" cytoplasm | Foamy/vacuolated cytoplasm |
| Cherry-red spot | Present (nearly all) | Absent | Present (Type A, ~50%) |
| CNS involvement | Severe | Absent (Type I) | Severe (Type A) |
| Ethnic predisposition | Ashkenazic Jews | Ashkenazic Jews | Ashkenazic Jews |
| Treatment | None effective | ERT (imiglucerase) | None curative |
| Prognosis | Fatal by age 2-3 | Good (Type I) | Fatal by age 2-3 (Type A) |
Sources: Robbins & Cotran Pathologic Basis of Disease (Robbins, Cotran & Kumar) and Robbins & Kumar Basic Pathology - both from the digital library. These are the standard global reference texts in pathology and the content mirrors what is presented in Harsh Mohan's Textbook of Pathology (9th edition) on these topics.